180 related articles for article (PubMed ID: 36400876)
1. The diagnostic and prognostic potential of the EGFR/MUC4/MMP9 axis in glioma patients.
Quesnel A; Coles N; Polvikoski TM; Karagiannis GS; Angione C; Islam M; Khundakar AA; Filippou PS
Sci Rep; 2022 Nov; 12(1):19868. PubMed ID: 36400876
[TBL] [Abstract][Full Text] [Related]
2. MUC4 modulates human glioblastoma cell proliferation and invasion by upregulating EGFR expression.
Li W; Wu C; Yao Y; Dong B; Wei Z; Lv X; Zhang J; Xu Y
Neurosci Lett; 2014 Apr; 566():82-7. PubMed ID: 24582898
[TBL] [Abstract][Full Text] [Related]
3. MUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells.
Mukhopadhyay P; Lakshmanan I; Ponnusamy MP; Chakraborty S; Jain M; Pai P; Smith LM; Lele SM; Batra SK
PLoS One; 2013; 8(2):e54455. PubMed ID: 23408941
[TBL] [Abstract][Full Text] [Related]
4. Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimens.
Comincini S; Paolillo M; Barbieri G; Palumbo S; Sbalchiero E; Azzalin A; Russo MA; Schinelli S
J Biomed Biotechnol; 2009; 2009():924565. PubMed ID: 19657395
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.
Wang F; Xiao W; Sun J; Han D; Zhu Y
Tumour Biol; 2014 Sep; 35(9):8653-8. PubMed ID: 24867100
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of Matrix Metalloproteinase Family Members Reveals That MMP9 Predicts Survival and Response to Temozolomide in Patients with Primary Glioblastoma.
Li Q; Chen B; Cai J; Sun Y; Wang G; Li Y; Li R; Feng Y; Han B; Li J; Tian Y; Yi L; Jiang C
PLoS One; 2016; 11(3):e0151815. PubMed ID: 27022952
[TBL] [Abstract][Full Text] [Related]
7. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor serum levels and prognostic value in malignant gliomas.
Quaranta M; Divella R; Daniele A; Di Tardo S; Venneri MT; Lolli I; Troccoli G
Tumori; 2007; 93(3):275-80. PubMed ID: 17679463
[TBL] [Abstract][Full Text] [Related]
9. Mucin O-glycosylating enzyme GALNT2 facilitates the malignant character of glioma by activating the EGFR/PI3K/Akt/mTOR axis.
Sun Z; Xue H; Wei Y; Wang C; Yu R; Wang C; Wang S; Xu J; Qian M; Meng Q; Li G
Clin Sci (Lond); 2019 May; 133(10):1167-1184. PubMed ID: 31076460
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of FoxO1 nuclear exclusion prevents metastasis of glioblastoma.
Chen J; Huang Q; Wang F
Tumour Biol; 2014 Jul; 35(7):7195-200. PubMed ID: 24771221
[TBL] [Abstract][Full Text] [Related]
11. The expression and prognostic value of the epidermal growth factor receptor family in glioma.
Xu B; Huo Z; Huang H; Ji W; Bian Z; Jiao J; Sun J; Shao J
BMC Cancer; 2021 Apr; 21(1):451. PubMed ID: 33892666
[TBL] [Abstract][Full Text] [Related]
12. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
13. Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.
Joseph C; Alsaleem M; Orah N; Narasimha PL; Miligy IM; Kurozumi S; Ellis IO; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jul; 182(2):267-282. PubMed ID: 32445177
[TBL] [Abstract][Full Text] [Related]
14. High expression of MMP9 in glioma affects cell proliferation and is associated with patient survival rates.
Xue Q; Cao L; Chen XY; Zhao J; Gao L; Li SZ; Fei Z
Oncol Lett; 2017 Mar; 13(3):1325-1330. PubMed ID: 28454256
[TBL] [Abstract][Full Text] [Related]
15. Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases.
Rokutan-Kurata M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Koyama M; Shigeto S; Fujimoto M; Zhang M; Morita S; Date H; Haga H
Clin Lung Cancer; 2017 Jul; 18(4):e273-e281. PubMed ID: 28065467
[TBL] [Abstract][Full Text] [Related]
16. TRAF6 correlated to invasion and poor prognosis of glioblastoma via elevating MMP9 expression.
Sun J; Zhao B; Du K; Liu P
Neuroreport; 2019 Jan; 30(2):127-133. PubMed ID: 30571666
[TBL] [Abstract][Full Text] [Related]
17. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
[TBL] [Abstract][Full Text] [Related]
18. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
[TBL] [Abstract][Full Text] [Related]
19. The Histone Demethylase NO66 Induces Glioma Cell Proliferation.
Wang Q; Liu PY; Liu T; Lan Q
Anticancer Res; 2019 Nov; 39(11):6007-6014. PubMed ID: 31704826
[TBL] [Abstract][Full Text] [Related]
20. MUC4-promoted neural invasion is mediated by the axon guidance factor Netrin-1 in PDAC.
Wang L; Zhi X; Zhu Y; Zhang Q; Wang W; Li Z; Tang J; Wang J; Wei S; Li B; Zhou J; Jiang J; Yang L; Xu H; Xu Z
Oncotarget; 2015 Oct; 6(32):33805-22. PubMed ID: 26393880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
